News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Harris Todd
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/15/2023 |
4
| Harris Todd (CEO) has filed a Form 4 on Tyra Biosciences, Inc.|
Txns:
| Sold 7,927 shares
@ $16.0048, valued at
$126.9k
Sold 12,773 shares
@ $16.1275, valued at
$206k
Exercised 7,927 options to buy
@ $2.25, valued at
$17.8k
Exercised 12,773 options to buy
@ $2.25, valued at
$28.7k
|
|
| 04/05/2023 |
4
| Harris Todd (CEO) has filed a Form 4 on Tyra Biosciences, Inc.|
Txns:
| Sold 2,000 shares
@ $16.126, valued at
$32.3k
Exercised 2,000 options to buy
@ $2.25, valued at
$4.5k
|
|
| 03/31/2023 |
4
| Harris Todd (CEO) has filed a Form 4 on Tyra Biosciences, Inc.|
Txns:
| Sold 1,420 shares
@ $16.1835, valued at
$23k
Sold 2,407 shares
@ $16.0166, valued at
$38.6k
Sold 500 shares
@ $16.046, valued at
$8k
Exercised 1,420 options to buy
@ $2.25, valued at
$3.2k
Exercised 2,407 options to buy
@ $2.25, valued at
$5.4k
Exercised 500 options to buy
@ $2.25, valued at
$1.1k
|
|
| 03/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/23/2023 |
4
| Harris Todd (CEO) has filed a Form 4 on Tyra Biosciences, Inc.|
Txns:
| Sold 12,393 shares
@ $16, valued at
$198.3k
Sold 4,043 shares
@ $16, valued at
$64.7k
Sold 2,800 shares
@ $16, valued at
$44.8k
Exercised 12,393 options to buy
@ $2.25, valued at
$27.9k
Exercised 4,043 options to buy
@ $2.25, valued at
$9.1k
Exercised 2,800 options to buy
@ $2.25, valued at
$6.3k
|
|
| 03/17/2023 |
4
| Harris Todd (CEO) has filed a Form 4 on Tyra Biosciences, Inc.|
Txns:
| Granted 1,808 shares
@ $6.579, valued at
$11.9k
|
|
| 09/08/2022 |
4
| Harris Todd (CEO) has filed a Form 4 on Tyra Biosciences, Inc.|
Txns:
| Granted 3,125 shares
@ $8.5255, valued at
$26.6k
Granted 270,000 options to buy
@ $7.14, valued at
$1.9M
|
|
| 11/04/2021 |
4
| Harris Todd (CEO) has filed a Form 4 on Tyra Biosciences, Inc.|
Txns:
| Granted 215,038 options to buy
@ $24.15, valued at
$5.2M
Granted 25,884 options to buy
@ $24.15, valued at
$625.1k
|
|
| 09/17/2021 |
4
| Harris Todd (CEO) has filed a Form 4 on Tyra Biosciences, Inc.|
Txns:
| Converted 34,007 shares
@ $0
Converted 13,093 preferred shares
@ $0 |
|
| 09/14/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/03/2019 |
4
| Harris Todd (Director) has filed a Form 4 on Sienna Biopharmaceuticals, Inc.|
Txns:
| Granted 25,000 options to buy
@ $1.22, valued at
$30.5k
|
|
| 05/02/2018 |
4
| Harris Todd (Head of Corporate Development) has filed a Form 4 on Sienna Biopharmaceuticals, Inc.|
Txns:
| Sold 100 shares
@ $20, valued at
$2k
|
|
| 04/25/2018 |
4
| Harris Todd (Head of Corporate Development) has filed a Form 4 on Sienna Biopharmaceuticals, Inc.|
Txns:
| Sold 525 shares
@ $20, valued at
$10.5k
Sold 150 shares
@ $20, valued at
$3k
Sold 300 shares
@ $20, valued at
$6k
|
|
| 04/19/2018 |
4
| Harris Todd (Head of Corporate Development) has filed a Form 4 on Sienna Biopharmaceuticals, Inc.|
Txns:
| Sold 2,201 shares
@ $20, valued at
$44k
Sold 15,810 shares
@ $20.0885, valued at
$317.6k
|
|
| 04/12/2018 |
4
| Harris Todd (Head of Corporate Development) has filed a Form 4 on Sienna Biopharmaceuticals, Inc.|
Txns:
| Sold 3,779 shares
@ $20.0161, valued at
$75.6k
|
|
| 04/09/2018 |
4
| Harris Todd (Head of Corporate Development) has filed a Form 4 on Sienna Biopharmaceuticals, Inc.|
Txns:
| Sold 5,386 shares
@ $20.001, valued at
$107.7k
Sold 2,824 shares
@ $20, valued at
$56.5k
|
|
| 03/20/2018 |
4
| Harris Todd (Head of Corporate Development) has filed a Form 4 on Sienna Biopharmaceuticals, Inc.|
Txns:
| Sold 5,876 shares
@ $20, valued at
$117.5k
|
|
| 03/14/2018 |
4
| Harris Todd (Head of Corporate Development) has filed a Form 4 on Sienna Biopharmaceuticals, Inc.|
Txns:
| Sold 3,452 shares
@ $20.1127, valued at
$69.4k
|
|
| 03/09/2018 |
4
| Harris Todd (Head of Corporate Development) has filed a Form 4 on Sienna Biopharmaceuticals, Inc.|
Txns:
| Sold 3,704 shares
@ $20, valued at
$74.1k
Sold 14,530 shares
@ $20.0342, valued at
$291.1k
Sold 2,438 shares
@ $20.0099, valued at
$48.8k
|
|
| 07/27/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/26/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|